Considered and approved Shifting of Registered Office of the Company within local limits of the City.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd (formerly Kamron Laboratories) held a board meeting on June 13, 2025, approving several key decisions. The company is shifting its registered office within Ahmedabad city limits. Mr. Kuldip Parekh resigned as CFO, and Mr. Hardik Vaghasiya was appointed as the new CFO; Ms. Akshita Khandelwal was appointed as Company Secretary & Compliance Officer replacing Mrs. Ritu Singh. Two new Non-Executive Independent Directors — Mr. Him Vyas and Mr. Krish Patel — were appointed for 5-year terms. The 37th AGM is scheduled for July 11, 2025, via video conferencing, with M/s. Ishit Vyas & Co. appointed as Secretarial Auditors for five years (FY 2025-26 to 2029-30). Most notably, the company approved a major amendment to its main object clause, subject to shareholder approval, adding new business areas including solar/renewable energy, engineering and procurement contracting, and commodity trading/organic farming — a significant diversification away from its core chemicals/lab business.
The MOA amendment signals a strategic pivot into renewable energy, infrastructure, and commodity trading, which could materially reshape the company's business profile and investor narrative. The complete overhaul of the KMP team (new CFO, new CS, two new independent directors) may raise governance and continuity questions in the short term, though the changes are routine. Shareholders should watch for the postal ballot/EGM outcome on the object clause change, as this is the most consequential item for future growth direction.